Drug delivery device

• US 20050137538A1
• Filed: 12/08/2004
• Published: 06/23/2005
• Est. Priority Date: 12/22/2003
• Status: Abandoned Application

• Current Assignee: Bausch & Lomb Incorporated (Bausch Health Cos., Inc.)
• Original Assignee: Bausch & Lomb Incorporated (Bausch Health Cos., Inc.)
• Inventors: Raiche, Adrian, Kunzler, Jay F., Jani, Dharmendra M.
• Application Number:
  US11/006,914
• Publication Number:
  US 20050137538A1
• Time in Patent Office: Days
• US Class Current: 604/294
• CPC Class Codes: A61F 2250/0067 Means for introducing or releasing pharmaceutical products into the body
• CPC Class Codes: A61F 9/0017 implantable in, or in contact with, the eye, e.g. ocular inserts

Abstract

A drug delivery device for placement in the eye includes a drug core comprising a pharmaceutically active agent, and a holder that holds the drug core. The holder is made of a material impermeable to passage of the active agent and includes an opening for passage of the pharmaceutically agent therethrough to eye tissue. The device includes a layer of material permeable to passage of the active agent. The device further includes a disc of impermeable material disposed between the drug core and the opening in the holder.

Claims

1. A drug delivery device comprising:

a holder made of a material impermeable to passage of a pharmaceutically active agent, and including at least one opening for passage of the active agent therethrough;

a drug core contained in the holder, and including a pharmaceutically active agent; and

a preformed disc made of an expandable material permeable to passage of the active agent, the disc contained in the holder and disposed between the drug core and the at least one opening in the holder,

wherein a groove is formed in the holder in the vicinity of the disc.

2. The device of claim 1, wherein the groove and disc are circular, and the groove has a larger diameter than a diameter of the disc when in an unexpanded state.

3. The device of claim 2, wherein the disc expands upon exposure to body fluid and expands into the groove.

4. The device of claim 1, wherein the groove is larger than the disc when in an unexpanded state.

5. The device of claim 4, wherein the disc expands upon exposure to body fluid and expands into the groove.

6. The device of claim 1, further comprising a suture tab attached to the holder.

7. The device of claim 1, wherein the impermeable material comprises silicone.

8. The device of claim 1, wherein the drug core comprises a mixture of the active agent and a matrix material permeable to said active agent.

9. The device of claim 8, wherein the matrix material comprises polyvinyl alcohol.

10. The device of claim 1, wherein the disc material is a hydrogel.

11. The device of claim 10, wherein the disc material comprises polyvinyl alcohol.

12. The device of claim 1, wherein the holder comprises a cylinder that surrounds the drug core.

13. The device of claim 12, wherein an end of the cylinder includes at least one opening.

14. The device of claim 1, wherein the drug core is cylindrical.

15. The device of claim 1, wherein the drug core is coated with a material permeable to said active agent.

16. A drug delivery device comprising:

a holder made of a silicone material impermeable to passage of a pharmaceutically active agent, and including at least one opening for passage of the active agent therethrough;

a drug core contained in the holder, and including a pharmaceutically active agent and a matrix material permeable to the active agent;

a preformed disc made of a hydrogel material permeable to passage of the active agent, the disc contained in the holder and disposed between the drug core and the at least one opening in the holder,

wherein the disc swells upon exposure to body fluid thereby expanding into a space formed in the holder.

17. The device of claim 16, further comprising a suture tab attached to the holder.

18. The device of claim 16, wherein the space in the holder comprises an expansion groove formed in the holder interior.

19. The device of claim 16, which is sized for implantation in eye tissue.

20. The device of claim 19, further comprising a tab for suturing the device to the eye tissue.